1.
Long-term Outcomes of GATT for Glaucoma: ≥3 Year Follow-up at a UK Tertiary Center.
Aluzri Hussain, Soomro Shayan, Richardson Jay, Pandey Pravin, Mushtaq Fizza, Sung Velota C T et al.
J GlaucomaFeb 20260 citationsCase Series
GATT effectively lowers IOP and medication burden long-term (5.1 years), with 57.7% qualified success. Afro-Caribbean ethnicity, non-360° GATT, and early IOP spikes predict failure, guiding patient selection and management.